Study guide

6.3 Cardiac Assessment & ECG Interpretation

MRCP UK

Track your progress as you read

Finished sections get a check mark.

1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy

1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique

2 Clinical Sciences: Cellular, Genetic & Molecular Medicine

2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders

3 Clinical Sciences: Anatomy, Physiology & Immunology

3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions

4 Clinical Sciences: Statistics, Epidemiology & Trial Design

4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification

5 Clinical Pharmacology, Therapeutics & Toxicology

5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols

6 Cardiology: Coronary Artery Disease & Heart Failure

6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation

7 Cardiology: Arrhythmias, Valvular & Pericardial Disease

7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases

8 Respiratory Medicine: Airway & Parenchymal Lung Disease

8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis

9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders

9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing

10 Gastroenterology: Luminal Gastrointestinal Disease

10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia

11 Gastroenterology: Liver, Biliary & Pancreatic Disease

11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis

12 Endocrinology & Diabetes: Diabetes & Thyroid

12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules

13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium

13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease

14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease

14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases

15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance

15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis

16 Neurology: Cerebrovascular, Headache & Demyelinating Disease

16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases

17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease

17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders

18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease

18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies

19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy

19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease

20 Infectious Diseases & Tropical Medicine

20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites

21 Haematology: Anaemias & Red Cell Disorders

21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease

22 Haematology: Malignancy, Coagulation & Transfusion Medicine

22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions

23 Psychiatry in General Medicine

23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law

24 Geriatric Medicine

24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers

25 Dermatology

25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy

26 Oncology & Palliative Medicine

26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control

27 Medical Ophthalmology

27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease

6.3 Cardiac Assessment & ECG Interpretation

Key Takeaways Explain This Topic AI

The normal frontal cardiac axis spans -30° to +90°; left axis deviation (-30° to -90°) suggests left anterior fascicular block, inferior MI, or LVH, while right axis deviation (+90° to +180°) suggests left posterior fascicular block, RVH, or acute pulmonary embolism.

Corrected QT interval (Bazett formula: QTc = QT / sqrt(RR)) is prolonged when >450 ms in men and >460-470 ms in women; QTc >500 ms poses extreme risk of Torsades de Pointes, treated emergently with intravenous magnesium sulphate.

Acute myocardial infarction in the presence of left bundle branch block is diagnosed via the Sgarbossa criteria: concordant ST elevation >=1 mm (5 pts), concordant ST depression >=1 mm in V1-V3 (3 pts), or modified Smith-Sgarbossa excessively discordant ST/S ratio >=0.25 (score >=3 indicates acute occlusion).

Wellens syndrome presents with biphasic (Type A) or deeply inverted (Type B) T waves in V2-V3 during pain-free intervals, denoting critical proximal LAD stenosis; provocative exercise stress testing is strictly contraindicated due to imminent extensive anterior MI.

Acute pericarditis characteristically produces widespread concave saddle-shaped ST elevation with PR depression across limb and precordial leads, alongside reciprocal ST depression and PR elevation in lead aVR, without the localized vascular territoriality seen in STEMI.

Last updated: September 2026

Electrocardiography is a cornerstone of clinical practice and a prominent focus of MRCP(UK) Part 1 examinations. Candidates are tested on systematic analysis, precise interval calculations, conduction disturbances, bundle branch and fascicular blocks, chamber enlargement criteria, and critical high-risk patterns including Brugada, Wellens, de Winter, and pericarditis signatures.

  • 1. Systematic ECG Analysis, Axis Determination & Intervals
  • Standard Calibration & Systematic Approach

A standard diagnostic 12-lead ECG is recorded at a paper speed of 25 mm/s 25\text{ mm/s} 25 mm/s and voltage calibration of 10 mm/mV 10\text{ mm/mV} 10 mm/mV :

Time calibration: 1 small square ( 1 mm 1\text{ mm} 1 mm ) = 0.04 seconds 0.04\text{ seconds} 0.04 seconds ( 40 ms 40\text{ ms} 40 ms ); 1 large square ( 5 mm 5\text{ mm} 5 mm ) = 0.20 seconds 0.20\text{ seconds} 0.20 seconds ( 200 ms 200\text{ ms} 200 ms ); 5 large squares = 1.0 second 1.0\text{ second} 1.0 second .

Voltage calibration: 1 small square = 0.1 mV 0.1\text{ mV} 0.1 mV ; 1 large square = 0.5 mV 0.5\text{ mV} 0.5 mV ; 2 large squares ( 10 mm 10\text{ mm} 10 mm ) = 1.0 mV 1.0\text{ mV} 1.0 mV .

Heart Rate: In regular rhythms, rate equals 300 300 300 divided by the number of large squares between consecutive R waves ( 300 / RR 300 / \text{RR} 300/ RR ). In irregular rhythms (e.g., atrial fibrillation), count the number of QRS complexes on the 10-second rhythm strip and multiply by 6.

Mean Electrical Axis in the Frontal Plane

The mean frontal QRS axis is determined by examining limb leads I, II, and aVF:

Frontal Axis Angular Range Lead I Lead II Lead aVF Major Clinical Causes

Normal Axis − 30 ∘ to + 90 ∘ -30^\circ\text{ to }+90^\circ − 3 0 ∘ to + 9 0 ∘ Positive Positive Positive / Equiphasic Normal physiological variant

Left Axis Deviation (LAD) − 30 ∘ to − 90 ∘ -30^\circ\text{ to }-90^\circ − 3 0 ∘ to − 9 0 ∘ Positive Negative Negative Left anterior fascicular block (LAFB) , inferior MI, LVH, left bundle branch block, ventricular pacing

Right Axis Deviation (RAD) + 90 ∘ to + 180 ∘ +90^\circ\text{ to }+180^\circ + 9 0 ∘ to + 18 0 ∘ Negative Positive Positive Left posterior fascicular block (LPFB) , right ventricular hypertrophy, acute pulmonary embolism (cor pulmonale), lateral MI, COPD (vertical heart)

Extreme Axis Deviation − 90 ∘ to 180 ∘ -90^\circ\text{ to }180^\circ − 9 0 ∘ to 18 0 ∘ Negative Negative Negative Ventricular tachycardia (favours VT over SVT with aberrancy), hyperkalaemia, severe emphysema, ventricular pacing

Systematic Interval Analysis

PR Interval (Normal: 120 – 200 ms 120\text{–}200\text{ ms} 120 – 200 ms ; 3–5 small squares):

Prolonged ( > 200 ms > 200\text{ ms} > 200 ms ): First-degree atrioventricular (AV) block. Causes include degenerative conduction system disease (Lenègre-Lev disease), vagal hypertonia, Lyme carditis, inferior ischaemia, and AV nodal-blocking medications (beta-blockers, non-dihydropyridine CCBs, digoxin).

Shortened ( < 120 ms < 120\text{ ms} < 120 ms ): Pre-excitation via an accessory pathway bypass tract ( Wolff-Parkinson-White [WPW] syndrome , featuring a delta wave and widened QRS), Lown-Ganong-Levine syndrome, or junctional rhythm.

QRS Duration (Normal: < 120 ms < 120\text{ ms} < 120 ms ; < 3 < 3 < 3 small squares):

Prolongation ( ≥ 120 ms \ge 120\text{ ms} ≥ 120 ms ) indicates intraventricular conduction delay, bundle branch block, ventricular pacing, pre-excitation, or ventricular origin of depolarisation.

Corrected QT Interval (QTc):

Calculated via Bazett's formula : QTc = QT / RR (in seconds) \text{QTc} = \text{QT} / \sqrt{\text{RR (in seconds)}} QTc = QT / RR (in seconds) ​ . Overcorrects at high heart rates; Fridericia's formula ( QT / RR 3 \text{QT} / \sqrt[3]{\text{RR}} QT / 3 RR ​ ) is preferred at rates > 80 bpm > 80\text{ bpm} > 80 bpm .

Normal values: Men ≤ 450 ms \le 450\text{ ms} ≤ 450 ms ; Women ≤ 460 ms \le 460\text{ ms} ≤ 460 ms .

Borderline: Men 450 – 470 ms 450\text{–}470\text{ ms} 450 – 470 ms ; Women 460 – 480 ms 460\text{–}480\text{ ms} 460 – 480 ms .

Prolonged: Men > 470 ms > 470\text{ ms} > 470 ms ; Women > 480 ms > 480\text{ ms} > 480 ms . Values > 500 ms > 500\text{ ms} > 500 ms confer extreme risk for early afterdepolarizations triggering Torsades de Pointes (polymorphic VT) .

Etiologies:

Congenital: Romano-Ward syndrome (autosomal dominant; normal hearing; K C N Q 1 , K C N H 2 , S C N 5 A KCNQ1, KCNH2, SCN5A K CNQ 1 , K CN H 2 , SCN 5 A ), Jervell and Lange-Nielsen syndrome (autosomal recessive; with sensorineural deafness; K C N Q 1 , K C N E 1 KCNQ1, KCNE1 K CNQ 1 , K CNE 1 ).

Acquired: Electrolyte disturbances (hypokalaemia, hypomagnesaemia, hypocalcaemia), hypothermia (Osborn / J waves), severe intracranial hemorrhage (giant negative "cerebral T waves"), and QT-prolonging drugs (antiarrhythmics class Ia [procainamide, quinidine] and class III [amiodarone, sotalol]; psychotropics [citalopram, haloperidol, chlorpromazine, TCAs]; antimicrobials [erythromycin, clarithromycin, ciprofloxacin, moxifloxacin]; and antiemetics [ondansetron]).

Emergency Management of Torsades de Pointes: Immediate intravenous magnesium sulphate ( 2 g 2\text{ g} 2 g bolus over 10–15 minutes) regardless of baseline serum magnesium; temporary transvenous overdrive pacing ( 90 – 110 bpm 90\text{–}110\text{ bpm} 90 – 110 bpm ) or isoprenaline infusion; unsynchronized electrical defibrillation if haemodynamically unstable.

  • 2. Conduction Disturbances: Bundle Branch & Fascicular Blocks
  • Left vs. Right Bundle Branch Block

Left Bundle Branch Block (LBBB):

QRS duration ≥ 120 ms \text{QRS duration} \ge 120\text{ ms} QRS duration ≥ 120 ms .

Broad, notched, or slurred R waves in lateral leads (I, aVL, V5, V6) with absent septal Q waves ("M" pattern in V6).

Deep, wide QS or rS complex in lead V1 ("W" pattern in V1). Mnemonic: WiLLiaM ( W W W in V1, M M M in V6).

Secondary repolarisation abnormalities: Appropriate T-wave discordance (ST depression and T-wave inversion opposite the main QRS deflection).

Right Bundle Branch Block (RBBB):

QRS duration ≥ 120 ms \text{QRS duration} \ge 120\text{ ms} QRS duration ≥ 120 ms .

Triphasic r S R ′ rSR' r S R ′ , r s R ′ rsR' rs R ′ , or notched R wave in right precordial leads V1–V2 ("M" pattern in V1).

Wide, slurred S wave in lateral leads I, aVL, V5, and V6 ("W" pattern in V6). Mnemonic: MaRRoW ( M M M in V1, W W W in V6).

Normal septal Q waves are preserved; isolated RBBB does not obscure ischaemic ST deviations.

Diagnosing Acute MI in the Presence of LBBB: Sgarbossa Criteria

LBBB normally masks acute transmural STEMI due to altered initial septal and ventricular depolarisation. The Sgarbossa criteria restore diagnostic accuracy:

Concordant ST-segment elevation ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm ( 0.1 mV 0.1\text{ mV} 0.1 mV ) in any lead with a positive QRS complex ( 5 points ).

Concordant ST-segment depression ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm ( 0.1 mV 0.1\text{ mV} 0.1 mV ) in leads V1, V2, or V3 ( 3 points ).

Modified Smith-Sgarbossa Criterion (Excessive Discordance): Discordant ST-segment elevation ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm with an ST / S ratio ≥ 0.25 \text{ST}/\text{S ratio} \ge 0.25 ST / S ratio ≥ 0.25 ( 25 % 25\% 25% ) (measured as ST elevation at the J-point divided by the preceding negative S-wave amplitude). This replaces the original rule of discordant ST elevation ≥ 5 mm \ge 5\text{ mm} ≥ 5 mm .

A score of ≥ 3 \ge 3 ≥ 3 points carries a specificity > 98 % > 98\% > 98% for acute coronary occlusion, mandating emergent primary PCI pathway activation.

Fascicular, Bifascicular & Trifascicular Blocks

The left bundle branch bifurcates into a thin left anterior fascicle and a broad left posterior fascicle:

Left Anterior Fascicular Block (LAFB): LAD ( − 45 ∘ to − 90 ∘ -45^\circ\text{ to }-90^\circ − 4 5 ∘ to − 9 0 ∘ ), small q q q in I and aVL, small r r r in II, III, aVF, and normal QRS duration ( < 120 ms < 120\text{ ms} < 120 ms ).

Left Posterior Fascicular Block (LPFB): RAD ( + 90 ∘ to + 180 ∘ +90^\circ\text{ to }+180^\circ + 9 0 ∘ to + 18 0 ∘ ), small r r r in I and aVL, small q q q in II, III, aVF, normal QRS duration ( < 120 ms < 120\text{ ms} < 120 ms ), with exclusion of RVH or lateral MI.

Bifascicular Block: Combination of RBBB plus either LAFB (commonest) or RBBB plus LPFB .

Trifascicular Block: Bifascicular block plus first-degree AV block (prolonged PR interval), or alternating RBBB and LBBB. When accompanied by syncope, it carries high risk of complete heart block and warrants permanent pacemaker implantation.

3. Chamber Enlargement Criteria

Chamber Abnormality Key Electrocardiographic Criteria Clinical Significance & Associations

Left Ventricular Hypertrophy (LVH) Sokolow-Lyon: S V1 + R V5 or V6 ≥ 35 mm S_{\text{V1}} + R_{\text{V5 or V6}} \ge 35\text{ mm} S V1 ​ + R V5 or V6 ​ ≥ 35 mm ( 3.5 mV 3.5\text{ mV} 3.5 mV ), or R aVL ≥ 11 mm R_{\text{aVL}} \ge 11\text{ mm} R aVL ​ ≥ 11 mm .; Cornell Criteria: R aVL + S V3 > 28 mm R_{\text{aVL}} + S_{\text{V3}} > 28\text{ mm} R aVL ​ + S V3 ​ > 28 mm (men) or > 20 mm > 20\text{ mm} > 20 mm (women).; Associated with "LV strain": asymmetric downsloping ST depression and T-wave inversion in I, aVL, V5, V6 Chronic systemic hypertension, severe aortic stenosis, hypertrophic cardiomyopathy, coarctation of aorta

Right Ventricular Hypertrophy (RVH) Dominant R R R wave in V1 ( R / S ratio > 1 R/S \text{ ratio} > 1 R / S ratio > 1 or R V1 > 7 mm R_{\text{V1}} > 7\text{ mm} R V1 ​ > 7 mm ).; Prominent S S S wave in lateral leads ( R / S in V6 < 1 R/S \text{ in V6} < 1 R / S in V6 < 1 ).; Right axis deviation ( > + 90 ∘ > +90^\circ > + 9 0 ∘ ).; "RV strain" pattern: ST depression and T-wave inversion in V1–V3 and inferior leads Chronic pulmonary arterial hypertension, cor pulmonale, severe pulmonary valve stenosis, mitral stenosis

Left Atrial Enlargement (P mitrale) Broad, bifid/notched P wave in lead II with duration ≥ 120 ms \ge 120\text{ ms} ≥ 120 ms (inter-peak distance ≥ 40 ms \ge 40\text{ ms} ≥ 40 ms ).; Biphasic P wave in lead V1 with prominent, deep terminal negative deflection ( ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm depth and ≥ 40 ms \ge 40\text{ ms} ≥ 40 ms duration; Morris index) Mitral stenosis, severe mitral regurgitation, long-standing LV diastolic hypertension

Right Atrial Enlargement (P pulmonale) Tall, peaked, narrow P wave in lead II, III, and aVF with amplitude ≥ 2.5 mm \ge 2.5\text{ mm} ≥ 2.5 mm ( 0.25 mV 0.25\text{ mV} 0.25 mV ) and normal duration ( < 120 ms < 120\text{ ms} < 120 ms ).; Positive initial P-wave deflection in lead V1 > 1.5 mm > 1.5\text{ mm} > 1.5 mm Severe chronic obstructive pulmonary disease, pulmonary hypertension, tricuspid stenosis, pulmonary embolism

  • 4. High-Yield Non-Ischaemic & Diagnostic Ischaemic ECG Signatures
  • Brugada Syndrome

An autosomal dominant cardiac channelopathy primarily caused by loss-of-function mutations in the S C N 5 A SCN5A SCN 5 A gene (encoding the cardiac Nav1.5 voltage-gated sodium channel alpha-subunit).

Type 1 Pattern (Diagnostic): Coved-type ST-segment elevation ≥ 2.0 mm \ge 2.0\text{ mm} ≥ 2.0 mm ( 0.2 mV 0.2\text{ mV} 0.2 mV ) followed by a negative T wave in one or more right precordial leads (V1–V2, placed in the 4th, 3rd, or 2nd intercostal space).

Type 2 (Saddleback): ST elevation ≥ 2.0 mm \ge 2.0\text{ mm} ≥ 2.0 mm with a trough ≥ 1.0 mm \ge 1.0\text{ mm} ≥ 1.0 mm and positive or biphasic T wave.

Triggers & Risk: Unmasked by fever, high ambient temperature, alcohol, or sodium channel blockers (ajmaline, flecainide, procainamide). High risk of polymorphic VT, VF, and nocturnal sudden cardiac death; definitive management is an implantable cardioverter-defibrillator (ICD) .

Wellens Syndrome

Characterizes severe, critical ( > 90 % > 90\% > 90% ) stenosis of the proximal left anterior descending (LAD) coronary artery :

Diagnostic Criteria:

Deeply inverted or biphasic T waves in leads V2 and V3 (often extending V1–V6).

Recorded during a pain-free interval in a patient with recent typical angina.

Normal or minimally elevated cardiac enzymes.

Absence of pathological precordial Q waves and preserved R-wave progression.

Minimal or absent ST-segment elevation ( < 1 mm < 1\text{ mm} < 1 mm ).

Variants: Type A (~25%): Biphasic T waves in V2–V3. Type B (~75%): Deep, symmetrical, sharply inverted T waves in V2–V3.

Critical Management Pearl: Provocative exercise stress testing is strictly contraindicated (precipitates massive transmural anterior MI or fatal ventricular arrhythmias). Patients require urgent invasive coronary angiography.

de Winter T Waves

An acute STEMI equivalent identified in ~2% of acute proximal LAD occlusions:

Diagnostic ECG Features:

Upsloping ST-segment depression ( 1 – 3 mm 1\text{–}3\text{ mm} 1 – 3 mm ) at the J-point in precordial leads V1–V6.

Tall, prominent, symmetrical T waves with a sharp take-off in leads V1–V6.

ST-segment elevation ( 0.5 – 1.0 mm 0.5\text{–}1.0\text{ mm} 0.5 – 1.0 mm ) in lead aVR.

Absence of classic convex ST elevation across anterior chest leads.

Mandates immediate catheterization laboratory activation for primary PCI.

Acute Pericarditis vs. Acute STEMI

Pericardial inflammation alters ventricular and atrial epicardial repolarisation through 4 classical stages:

Stage 1 ECG Features:

Widespread, concave ("saddle-shaped") ST elevation in almost all limb and precordial leads (I, II, III, aVF, aVL, V2–V6).

Widespread PR-segment depression (reflects atrial subepicardial injury).

Reciprocal changes isolated strictly to lead aVR: Reciprocal ST-segment depression and PR-segment elevation in lead aVR (and occasionally lead V1).

Spodick's Sign: Downsloping of the TP segment, present in ~80% of cases.

Distinguishing from STEMI: Pericarditis does not follow a regional coronary vascular territory, lacks convex ("tombstone") ST morphology, exhibits widespread PR depression, lacks reciprocal ST depression in opposing vascular territories (e.g., lead III vs lead aVL), and never generates pathological Q waves. First-line therapy is high-dose NSAIDs (e.g., ibuprofen 600 mg tds or aspirin 750–1000 mg tds) plus colchicine (0.5 mg od or bd for 3 months) to prevent recurrences.